Wilson M. Compton, MD, MPE; Nora D. Volkow, MD; Douglas C. Throckmorton, MD; Peter Lurie, MD, MPH
Disclaimer: The views and opinions expressed in this commentary are those of the authors and should not be construed to represent the views of the National Institute on Drug Abuse, the National Institutes of Health, the U.S. Food and Drug Administration, or the U.S. government.
Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2814.
Requests for Single Reprints: Wilson M. Compton, MD, MPE, National Institute on Drug Abuse, 6001 Executive Boulevard, MSC 9589, Bethesda, MD 20892-9589; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Compton: National Institute on Drug Abuse, 6001 Executive Boulevard, MSC 9589, Bethesda, MD 20892-9589.
Dr. Throckmorton: U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 51, Room 6132, Silver Spring, MD 20993.
Dr. Lurie: U.S. Food and Drug Administration, Office of the Commissioner, 10903 New Hampshire Avenue, Building 1, Room 2320, Silver Spring, MD 20993.
Dr. Volkow: National Institute on Drug Abuse, 6001 Executive Boulevard, Bethesda, MD 20892.
Learn more about subscription options.
Register Now for a free account.
Compton WM, Volkow ND, Throckmorton DC, Lurie P. Expanded Access to Opioid Overdose Intervention: Research, Practice, and Policy Needs. Ann Intern Med. 2013;158:65–66. doi: 10.7326/0003-4819-158-1-201301010-00013
Download citation file:
Published: Ann Intern Med. 2013;158(1):65-66.
Emergency Medicine, Healthcare Delivery and Policy, Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only